News New guidance covers AI-based biomarkers for cancer care ESMO guidance on the validation and clinical use of AI-based biomarkers in oncology aims to strike a balance between caution and over-reliance.
News Change at the top of Recursion as co-founder leaves CEO role After 12 years as CEO of 'techbio' player Recursion, Chris Gibson is switching to the role of chair and will be replaced by Najat Khan.
News One Drop founder announces broad market CGM on Frontiers sta... One Drop founder Jeff Dachis brought his new product out of stealth mode at Frontiers Health -- a CGM for use beyond Type 1 diabetes.
News AI features in UK plan to reduce animal testing The UK government has set out an ambitious plan to phase out animal testing in scientific studies within five years.
News AHA: Cash for drug adherence study has disappointing result People with hypertension were twice as likely to take medicine regularly when offered cash rewards, but that didn't improve their blood pressure.
News Thermo bids $8.9bn for clinical trial data firm Clario Thermo Fisher Scientific has signed a deal to acquire Clario for nearly $8.9bn in cash in a major expansion of its clinical research capabilities.
Oncology ASCO 2026: All about DNA damage response, with Luke Piggot Luke Piggot, a principal scientist at Debiopharm, shares some recent data and news about the company's work in DNA damage repair inhibitors.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.